Shanghai Virginia Pharmaceutical Technology Co Ltd, specializing in providing comprehensive services for pharmaceutical companies to expand overseas, has moved in the Waigaoqiao Free Trade Zone, marking a further expansion of Shanghai Virginia to aid more domestic pharmaceutical companies in entering international markets.
Shanghai Virginia is a subsidiary of Virginia Contract Research Organization, founded in 1997, a CRO institution specializing in the registration and application of new drugs and medical devices. Over the years, Virginia has accumulated over 50 domestic and international projects, covering areas such as traditional Chinese medicine, biological products, and cutting-edge cell and gene therapy.
Shanghai Virginia will provide clients with end-to-end services, including strategic planning for early product development, medical registration submissions, and clinical operations, helping pharmaceutical companies expand into international markets.
The Waigaoqiao Free Trade Zone, with its international business environment and the comprehensive service platform of the Waigaoqiao Group, offers Shanghai Virginia ample development opportunities.
